FINWIRES · TerminalLIVE
FINWIRES

Top Midday Stories: Cisco Shares Soar as Guidance Tops Consensus; Alibaba, JD Reportedly Cleared to Buy Nvidia H200 AI Chips

By

All three major US stock indexes were up in late-morning trading Thursday, as investors monitor news emanating from President Donald Trump's meeting with Chinese President Xi Jinping in Beijing.

In company news, Cisco Systems (CSCO) reported fiscal Q3 adjusted earnings late Wednesday of $1.06 per diluted share, up from $0.96 a year earlier and above the FactSet consensus analyst estimate of $1.03. Fiscal Q3 revenue was $15.8 billion, up from $14.1 billion a year ago and above the FactSet consensus of $15.6 billion. For fiscal Q4, Cisco said it expects Q4 adjusted EPS of $1.16 to $1.18 on revenue of $16.7 billion to $16.9 billion. Analysts polled by FactSet expect $1.08 and $15.8 billion, respectively. Cisco shares were up 15.0% around midday.

Alibaba (BABA) and JD.com (JD) are among the roughly 10 Chinese companies that have secured US clearance to buy Nvidia's (NVDA) H200 artificial intelligence chips, though no deliveries have been made yet, Reuters reported Thursday, citing three people familiar with the matter. Alibaba and JD shares were down 1.9% and 2.1%, respectively. Nvidia shares were up 4.6%.

Chinese President Xi Jinping told the chief executives of Apple (AAPL), Tesla (TSLA), Nvidia and other large companies that China will "open wider" to doing business, CNBC reported Thursday, citing a report from state-backed newspaper Xinhua. Apple shares were up 0.1%, while Tesla shares were up 0.8%.

Biogen (BIIB) said Thursday that a phase 2 study evaluating diranersen in patients with early Alzheimer's disease did not meet its primary endpoint evaluating dose response for change from baseline on the Clinical Dementia Rating-Sum of Boxes at Week 76. Biogen shares were down 5.0%.

Price: $117.40, Change: $+15.53, Percent Change: +15.24%

Related Articles

Australia

Contango Q1 Net Loss Narrows

Contango Silver and Gold (CTGO) shares were down more than 3% in Thursday trading after the company missed Q1 earnings expectations.The company reported a Q1 net loss Thursday of $0.83 per diluted share, narrowing from a loss of $1.88 a year earlier.Three analysts surveyed by FactSet expected earnings of $0.65.Price: $25.52, Change: $-0.84, Percent Change: -3.19%

$CTGO
Australia

Market Chatter: OpenAI Preparing for Possible Legal Action Against Apple

Microsoft-backed (MSFT) OpenAI is preparing possible legal action against Apple (AAPL) as the partnership between the two companies has become strained, Bloomberg reported Thursday, citing people familiar with the matter.OpenAI's lawyers are working with an outside law firm on a range of options, including sending Apple a notice alleging breach of contract without actually filing a full lawsuit at the outset, the report said, citing the people.OpenAI and Apple didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $297.73, Change: $-1.14, Percent Change: -0.38%

$AAPL$MSFT
Australia

Oppenheimer Raises Biogen Price Target to $300 From $275, Maintains Outperform Rating

Biogen (BIIB) has an average rating of overweight and mean price target of $0, according to analysts polled by FactSet.Price: $194.50, Change: $-10.03, Percent Change: -4.90%

$BIIB